Evidence map›Paper›PMID 24801551›Full record

ReviewNatural product reports2014

Mass spectrometry of natural products: current, emerging and future technologies.

Amina Bouslimani, Laura M Sanchez, Neha Garg, Pieter C Dorrestein

Abstract readReview
In one paragraph

Review in Natural product reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. LC-MS/MS-Based Untargeted Hydrophilic Metabolomics Using MS-DIAL.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. NPAnalytical chemistry · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Advances in Mass Spectrometry-Metabolomics Based Approaches.Advances in experimental medicine and biology · 2023
    Article
  16. Review
  17. Journal of enzyme inhibition and medicinal chemistry · 2022
    Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amina BouslimaniSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States.
Laura M Sanchez
Neha Garg
Pieter C Dorrestein

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
SYNTHETIC SYSTEMSP50GM085764 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HASTY, JEFF M, IDEKER, TREY · 2010 to 2018
$23.3M
The chemical and genetic basis of interspecies interactionsR01AI095125 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, POGLIANO, KIT J · 2011 to 2014
$2.4M
Experiment based genome mining of ribosomal natural productsR01GM097509 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C, MOORE, BRADLEY S · 2012 to 2015
$1.9M
Real-Time Imaging of metabolic CommunicationR01GM094802 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C · 2010 to 2013
$1.0M
Synapt ion mobility mass spectrometerS10RR029121 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C · 2011 to 2011
$802k
NCRR NIH HHS GMS10RR029121NCRR NIH HHS S10 RR029121NIAID NIH HHS AI095125NIAID NIH HHS R01 AI095125NIGMS NIH HHS GM085764NIGMS NIH HHS GM094802NIGMS NIH HHS GM097509NIGMS NIH HHS K12 GM068524NIGMS NIH HHS P50 GM085764NIGMS NIH HHS R01 GM094802NIGMS NIH HHS R01 GM097509
6 · The paper itself

Abstract

Although mass spectrometry is a century old technology, we are entering into an exciting time for the analysis of molecular information directly from complex biological systems. In this Highlight, we feature emerging mass spectrometric methods and tools used by the natural product community and give a perspective of future directions where the mass spectrometry field is migrating towards over the next decade.

Indexed as

Biological ProductsMass SpectrometryMolecular StructureBiological Products

Identifiers

PMID24801551
PMCPMC4161218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.